HCA Reports Third Quarter 2015 Results

Go back to HCA Reports Third Quarter 2015 Results

Uncompensated Care Negatively Hits HCA Holdings (HCA) 3Q Results

October 28, 2015 10:14 AM EDT

Leerink Partners maintained an Outperform rating on HCA Holdings (NYSE: HCA), and cut the price target to $79.00 (from $95.00), following the company's 3Q earnings results. HCA reported results consistent with its pre-announcement of a ~$60 MM EBITDA miss.

Analyst Ana Gupte commented, "HCA reported 3Q consistent with its pre-announcement of a ~$60 MM EBITDA miss ($1,815MM vs. our $1,878MM). Key highlights of the quarter were the continued sequential and YoY deterioration in payor mix, as measured by a 10.5% (vs. 7.9% Consensus) Bad Debt ratio, that... More

HCA Holdings' (HCA) Buyback Plan is Credit-Negative Event - Moody's

October 27, 2015 2:31 PM EDT

Moody's Investor Service commented that HCA Holdings, Inc.'s (NYSE: HCA) announced $3.0 billion share repurchase authorization is modestly credit negative. However, there is no impact on HCA's ratings, including the Ba2 Corporate Family Rating, or stable rating outlook.

... More

HCA Holdings (HCA) Misses Q3 EPS by 15c; Guides FY15 EPS Below Views

October 27, 2015 8:31 AM EDT

HCA Holdings (NYSE: HCA) reported Q3 EPS of $1.05, $0.15 worse than the analyst estimate of $1.20. Revenue for the quarter came in at $9.86 billion versus the consensus estimate of $9.9 billion.

The HCA Holdings, Inc. Board of Directors has authorized an additional share repurchase... More